122 related articles for article (PubMed ID: 8707926)
21. Mannose-binding Lectin Mediated Complement Pathway in Autoimmune Neurological Disorders.
Farrokhi M; Dabirzadeh M; Dastravan N; Etemadifar M; Ghadimi K; Saadatpour Z; Rezaei A
Iran J Allergy Asthma Immunol; 2016 Jun; 15(3):251-6. PubMed ID: 27424141
[TBL] [Abstract][Full Text] [Related]
22. [A study of soluble form of selectin family in the sera of patients with neuroimmunological disorders].
Sakai T; Inoue A; Koh CS; Yamazaki M; Yanagisawa N
Rinsho Shinkeigaku; 1998 Mar; 38(3):197-202. PubMed ID: 9711113
[TBL] [Abstract][Full Text] [Related]
23. Autoantibody-mediated dysfunction of sympathetic neurons in guillain-barre syndrome.
Lehmann HC; Jangouk P; Kierysch EK; Meyer zu Hörste G; Hartung HP; Kieseier BC
Arch Neurol; 2010 Feb; 67(2):203-10. PubMed ID: 20142528
[TBL] [Abstract][Full Text] [Related]
24. Serum and CSF humoral immunity in Guillain-Barré syndrome: clinical correlations.
Amarenco P; Sauron B; Schuller E; Chain F; Castaigne P
J Neurol Sci; 1987 Sep; 80(2-3):129-42. PubMed ID: 3119777
[TBL] [Abstract][Full Text] [Related]
25. Serum tryptophan, kynurenine, and neopterin in patients with Guillain-Barre-syndrome (GBS) and multiple sclerosis (MS).
Rudzite V; Berzinsh J; Grivane I; Fuchs D; Baier-Bitterlich G; Wachter H
Adv Exp Med Biol; 1996; 398():183-7. PubMed ID: 8906264
[No Abstract] [Full Text] [Related]
26. Soluble complement receptor type 1 (CD35) in bronchoalveolar lavage of inflammatory lung diseases.
Hamacher J; Sadallah S; Schifferli JA; Villard J; Nicod LP
Eur Respir J; 1998 Jan; 11(1):112-9. PubMed ID: 9543279
[TBL] [Abstract][Full Text] [Related]
27. Soluble E-selectin in the serum and cerebrospinal fluid of patients with multiple sclerosis and human T-lymphotropic virus type 1-associated myelopathy.
Tsukada N; Miyagi K; Matsuda M; Yanagisawa N
Neurology; 1995 Oct; 45(10):1914-8. PubMed ID: 7477992
[TBL] [Abstract][Full Text] [Related]
28. [A study of soluble form of L-selectin in blood of patients with neuroimmunological disorders].
Sakai T; Inoue A; Koh CS; Yamazaki M; Yanagisawa N
Arerugi; 1996 Jul; 45(7):672-7. PubMed ID: 8831172
[TBL] [Abstract][Full Text] [Related]
29. Increased intrathecal production of apolipoprotein D in multiple sclerosis.
Reindl M; Knipping G; Wicher I; Dilitz E; Egg R; Deisenhammer F; Berger T
J Neuroimmunol; 2001 Oct; 119(2):327-32. PubMed ID: 11585636
[TBL] [Abstract][Full Text] [Related]
30. Immunoglobulins in serum and cerebrospinal fluid from patients with acute Guillain-Barré syndrome.
Vedeler CA; Matre R; Nyland H
Acta Neurol Scand; 1986 Apr; 73(4):388-93. PubMed ID: 3727914
[TBL] [Abstract][Full Text] [Related]
31. Immune complexes and the complement factors C4 and C3 in cerebrospinal fluid and serum from patients with chronic progressive multiple sclerosis.
Jans H; Heltberg A; Zeeberg I; Kristensen JH; Fog T; Raun NE
Acta Neurol Scand; 1984 Jan; 69(1):34-8. PubMed ID: 6702418
[TBL] [Abstract][Full Text] [Related]
32. Elevated serum levels of IFN-gamma, IL-4 and TNF-alpha/unelevated serum levels of IL-10 in patients with demyelinating diseases during the acute stage.
Hohnoki K; Inoue A; Koh CS
J Neuroimmunol; 1998 Jul; 87(1-2):27-32. PubMed ID: 9670842
[TBL] [Abstract][Full Text] [Related]
33. Multiple sclerosis: IL-2 and sIL-2R levels in cerebrospinal fluid and serum. Review of literature and critical analysis of ELISA pitfalls.
Sivieri S; Ferrarini AM; Gallo P
Mult Scler; 1998 Feb; 4(1):7-11. PubMed ID: 9532585
[TBL] [Abstract][Full Text] [Related]
34. Increased intrathecal synthesis of fibronectin in bacterial and carcinomatous meningitis.
Weller M; Sommer N; Stevens A; Wiethölter H
Acta Neurol Scand; 1990 Aug; 82(2):138-42. PubMed ID: 2256444
[TBL] [Abstract][Full Text] [Related]
35. Pleocytosis and immunoglobulin changes in cerebrospinal fluid and herpesvirus serology in patients with Guillain-Barré syndrome.
Link H; Wahren B; Norrby E
J Clin Microbiol; 1979 Mar; 9(3):305-16. PubMed ID: 222797
[TBL] [Abstract][Full Text] [Related]
36. Observations on the effect of injection of lymphocytes from multiple sclerosis and Guillain-Barré syndrome in the rabbit eye model.
Kam-Hansen S; Kristensson K; Link H
J Neurol Sci; 1979 Jul; 42(2):283-9. PubMed ID: 479915
[TBL] [Abstract][Full Text] [Related]
37. A search for antibodies against glial cells in the serum and cerebrospinal fluid of patients with multiple sclerosis and Guillain-Barré syndrome.
Kennedy PG; Lisak RP
J Neurol Sci; 1979 Dec; 44(1):125-33. PubMed ID: 390102
[TBL] [Abstract][Full Text] [Related]
38. Role of complement in demyelination in vitro by multiple sclerosis serum and other neurological disease sera.
Bradbury K; Aparicio SR; Sumner DW; Bird CC
J Neurol Sci; 1984 Sep; 65(3):293-305. PubMed ID: 6491691
[TBL] [Abstract][Full Text] [Related]
39. CSF and serum levels of soluble interleukin-6 receptors (sIL-6R and sgp130), but not of interleukin-6 are altered in multiple sclerosis.
Padberg F; Feneberg W; Schmidt S; Schwarz MJ; Körschenhausen D; Greenberg BD; Nolde T; Müller N; Trapmann H; König N; Möller HJ; Hampel H
J Neuroimmunol; 1999 Oct; 99(2):218-23. PubMed ID: 10505978
[TBL] [Abstract][Full Text] [Related]
40. Serum interleukin-2 concentrations in Guillain-Barré syndrome and chronic idiopathic demyelinating polyradiculoneuropathy: comparison with other neurological diseases of presumed immunopathogenesis.
Hartung HP; Reiners K; Schmidt B; Stoll G; Toyka KV
Ann Neurol; 1991 Jul; 30(1):48-53. PubMed ID: 1929228
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
